These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 2564704

  • 1. Effects of nicotinic agonists and antagonists on N-methyl-D-aspartate-induced 3H-norepinephrine release and 3H-(1-[1-(2-thienyl)cyclohexyl]-piperidine) binding in rat hippocampus.
    Snell LD, Johnson KM.
    Synapse; 1989; 3(2):129-35. PubMed ID: 2564704
    [Abstract] [Full Text] [Related]

  • 2. Cholinergic modulation of N-methyl-D-aspartate-evoked [3H]norepinephrine release from rat cortical slices.
    Gonzales RA, Roper LC, Westbrook SL.
    J Pharmacol Exp Ther; 1993 Jan; 264(1):282-8. PubMed ID: 8423531
    [Abstract] [Full Text] [Related]

  • 3. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors.
    Rao TS, Correa LD, Lloyd GK.
    Neuropharmacology; 1997 Jan; 36(1):39-50. PubMed ID: 9144640
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.
    Sacaan AI, Dunlop JL, Lloyd GK.
    J Pharmacol Exp Ther; 1995 Jul; 274(1):224-30. PubMed ID: 7542334
    [Abstract] [Full Text] [Related]

  • 5. Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.
    Jones SM, Snell LD, Johnson KM.
    J Pharmacol Exp Ther; 1987 Feb; 240(2):492-7. PubMed ID: 2879908
    [Abstract] [Full Text] [Related]

  • 6. Ethanol inhibits N-methyl-D-aspartate-stimulated [3H]norepinephrine release from rat cortical slices.
    Gonzales RA, Woodward JJ.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1138-44. PubMed ID: 2162947
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
    Rao TS, Correa LD, Adams P, Santori EM, Sacaan AI.
    Brain Res; 2003 Nov 14; 990(1-2):203-8. PubMed ID: 14568345
    [Abstract] [Full Text] [Related]

  • 8. Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells.
    Reuben M, Louis M, Clarke PB.
    Br J Pharmacol; 1998 Nov 14; 125(6):1218-27. PubMed ID: 9863650
    [Abstract] [Full Text] [Related]

  • 9. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK, Sumithran SP, Dwoskin LP.
    J Pharmacol Exp Ther; 2002 Sep 14; 302(3):1113-22. PubMed ID: 12183670
    [Abstract] [Full Text] [Related]

  • 10. Assessment of nicotinic acetylcholine receptor-mediated release of [(3)H]-norepinephrine from rat brain slices using a new 96-well format assay.
    Anderson DJ, Puttfarcken PS, Jacobs I, Faltynek C.
    Neuropharmacology; 2000 Oct 14; 39(13):2663-72. PubMed ID: 11044736
    [Abstract] [Full Text] [Related]

  • 11. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
    Levin ED, Tizabi Y, Rezvani AH, Caldwell DP, Petro A, Getachew B.
    Brain Res; 2005 Apr 18; 1041(2):132-42. PubMed ID: 15829222
    [Abstract] [Full Text] [Related]

  • 12. Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release.
    Fedele E, Varnier G, Ansaldo MA, Raiteri M.
    Br J Pharmacol; 1998 Nov 18; 125(5):1042-8. PubMed ID: 9846643
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
    Khan IM, Taylor P, Yaksh TL.
    J Pharmacol Exp Ther; 1994 Jul 18; 270(1):150-8. PubMed ID: 8035311
    [Abstract] [Full Text] [Related]

  • 14. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM, Yaksh TL, Taylor P.
    J Pharmacol Exp Ther; 1994 Jul 18; 270(1):159-66. PubMed ID: 8035312
    [Abstract] [Full Text] [Related]

  • 15. Nicotine exerts a permissive role on NMDA receptor function in hippocampal noradrenergic terminals.
    Risso F, Grilli M, Parodi M, Bado M, Raiteri M, Marchi M.
    Neuropharmacology; 2004 Jul 18; 47(1):65-71. PubMed ID: 15165834
    [Abstract] [Full Text] [Related]

  • 16. Activity of putative cognition enhancers in kynurenate test performed with human neocortex slices.
    Pittaluga A, Pattarini R, Andrioli GC, Viola C, Munari C, Raiteri M.
    J Pharmacol Exp Ther; 1999 Jul 18; 290(1):423-8. PubMed ID: 10381808
    [Abstract] [Full Text] [Related]

  • 17. Allosteric interaction of the anticholinergic drug [N-(4-phenyl)-phenacyl-l-hyoscyamine] (Phenthonium) with nicotinic receptors of post-ganglionic sympathetic neurons of the rat vas deferens.
    Munhoz E, De Lima TC, Souccar C, Lapa AJ, Lima-Landman MT.
    Eur J Pharmacol; 2009 Aug 15; 616(1-3):229-35. PubMed ID: 19540221
    [Abstract] [Full Text] [Related]

  • 18. Enhancement by yohimbine of nicotine- and dimethylphenylpiperadinium-induced release of norepinephrine from cardiac sympathetic nerves of the dog: interaction of presynaptic alpha and nicotinic receptors.
    Kanda A, Koyanagawa H, Yorikane R, Kimura T, Satoh S.
    J Pharmacol Exp Ther; 1987 Dec 15; 243(3):1095-100. PubMed ID: 2826754
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
    Snell LD, Johnson KM.
    J Pharmacol Exp Ther; 1986 Sep 15; 238(3):938-46. PubMed ID: 2875174
    [Abstract] [Full Text] [Related]

  • 20. Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors.
    Fu Y, Matta SG, James TJ, Sharp BM.
    J Pharmacol Exp Ther; 1998 Mar 15; 284(3):1188-96. PubMed ID: 9495882
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.